I don't understand his assessment. If we are at a therapeutic dose and have finished monitoring the patients for the allotted time wouldn't it have to be disclosed to the shareholders? Wouldn't it be illegal to not disclose? I am not understanding his assessment.
- Forums
- ASX - By Stock
- BLT
- BLT.AX says CEO and Managing Director Dr Peter French Resigned
BLT.AX says CEO and Managing Director Dr Peter French Resigned, page-42
-
- There are more pages in this discussion • 73 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)